Conference Reports for NATAP

EASL - European Association for the Study of the Liver Barcelona, Spain May 27-30, 2026 Back

A single VRON-0200 prime dose, followed by a monthly antiviral combination regimen, resulted in rapid, profound, and durable HBsAg declines in chronically hepatitis B infected patients       EASL 2026 May 26-30 Barcelona   Download the PDF here